AG00IBC5

64221-86-9 | 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-

Chemical structure of 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-, CAS 64221-86-9
AG00IBC5
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 64221-86-9
Catalog Number AG00IBC5(AGN-PC-0TBV9Z)
Chemical Name 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-
EC Number 264-734-5
IUPAC Name (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
InChI InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1
InChI Key ZSKVGTPCRGIANV-ZXFLCMHBSA-N
MDL Number MFCD09753321
Molecular Formula C12H17N3O4S
Molecular Weight 299.3461
SMILES O=C(C(N12)=C(SCCNC=N)C[C@]2([H])[C@@H]([C@H](O)C)C1=O)O
UNII Q20IM7HE75
Synonyms
Anhydrous Imipenem, Anhydrous, Imipenem, Imipemide, Imipenem, Imipenem Anhydrous, Imipenem, Anhydrous, MK 0787, MK-0787, MK0787, N Formimidoylthienamycin, N-Formimidoylthienamycin, imipenem, Imipemide, 64221-86-9, N-Formimidoylthienamycin, Tienamycin, Imipenem anhydrous, Imipenemum, N-formimidoyl thienamycin, MK 0787, CHEBI:471744, Imipenem, N-Formimidoyl thienamycin, (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure, UNII-Q20IM7HE75, Imipenem (INN), Primaxin, CHEMBL148, Q20IM7HE75, (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, MK-0787, Imipenem [INN], Imipenemum [Latin], (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid, Imipenen, DSSTox_CID_3143, DSSTox_RID_76888, DSSTox_GSID_23143, (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, EINECS 264-734-5, MK-787, Thienamycin p-nitrobenzylester hydrochloride (N-methylpyrrolidinonesolvate), 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)-, CAS-64221-86-9, SR-05000000294, NCGC00016928-01, (5R,6S)-3-[2-(aminomethyleneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-(2-methanimidamidoethylsulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1R)-1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R,6S)-, Prestwick_844, AC1L2XLB, Prestwick0_000519, Prestwick1_000519, Prestwick2_000519, Prestwick3_000519, Epitope ID:120384, BSPBio_000477, BIDD:GT0686, SPBio_002398, BPBio1_000525, SCHEMBL1649260, SCHEMBL8781920, DTXSID2023143, ZSKVGTPCRGIANV-ZXFLCMHBSA-N, HMS1569H19, HMS2090A15, HMS2096H19, HMS3260H20, HMS3713H19, Pharmakon1600-01506001, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5-alpha,6-alpha(R*)))-, BCP13012, ZINC4097225, Tox21_110689, Tox21_500279, BDBM50049708, BDBM50213266, NSC717864, NSC759901, AKOS016010844, Tox21_110689_1, AN-9651, CCG-220519, CCG-221583, DB01598, LP00279, NSC-717864, NSC-759901, NCGC00167958-01, NCGC00167958-02, NCGC00167958-03, NCGC00167958-05, NCGC00260964-01, (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, AJ-47996, AN-15734, BC209124, FT-0627191, C06665, D04515, X-2302, AB01563339_01, 847I667, SR-05000000294-2, SR-05000000294-5, (5R,6S)-3-((2-formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-3-({2-[(E)-(aminomethylidene)amino]ethyl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-3-(2-formimidamidoethylthio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, [5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2- [(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylic acid monohydrate, 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-, 103730-39-8, 3-[(2-Aminoethyl)thio]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4-nitrophenyl)methylester monohydrochloride compd. with 1-methyl-2-pyrrolidinone (1:1), Imipenem hydrate, Zienam, Imipenem monohydrate, Anhydrous Imipenem, Imipenem-1-wasser, Primaxin (TN), Anhydrous, Imipenem, Imipenem, Anhydrous, Imipenem intermediate, Imipenem & clavulanate, N Formimidoylthienamycin, N-formimidoylthien-amycin, D0H3TD, UNII-71OTZ9ZE0A, cc-394, Imipenem and cilastatin sodium, C12H17N3O4S.H2O, C12H17N3O4S, Imipenem [USAN:BAN:INN:JAN], Imipenem [USAN:INN:BAN:JAN], KST-1A7214, AC-528, AR-1A6479, C12-H17-N3-O4-S, CID104838, MK0787, Imipenem [USAN:USP:INN:BAN:JAN], 3-(2-Naphthyl)-L-alanine Hydrochloride, 74431-23-5, C12-H17-N3-O4-S.H2-O, Ethyl alpha-methyl-beta-oxopyrazinepropionate, D015378, 442847-66-7, p-Nitrobenzyl -2- -6-( carbapen-2-em-3-carboxylate, IMP, 6623-14-9, IPM, (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid monohydrate, [5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))-, 85960-17-4,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited